The Food and Drug Administration (FDA or Agency) is announcing a public meeting to discuss proposed recommendations for the reauthorization of the Prescription Drug User Fee Act (PDUFA) for fiscal years (FYs) 2023 through 2027. The public meeting will be held at FDA’s White Oak Campus on July 23, 2020, from 9 a.m. to 2 p.m.
